Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Ramesh C. Gupta

Ramesh C. Gupta

Murray State University, USA

Title: Nutraceuticals In Animal Health And Disease, With A Special Reference To Osteoarthritis

Biography

Biography: Ramesh C. Gupta

Abstract

Currently, the nutraceutical industry is worth more than $200 billion per year. Nutraceuticals, commonly referred to as dietary supplements, are given to humans and animals with the intent of improvement of health, and prevention/treatment of diseases. In a number of animal diseases (such as arthritis, dermatitis, diabetes, depression, allergies, obesity, periodontal disease; and gastrointestinal, hepatic, renal, and cardiovascular dysfunction), nutraceuticals have been found very effective. Among all chronic diseases, osteoarthritis (OA) occurs with the greatest frequency, especially in canine and equine species. In fact, one in five adult dogs or horses is inflicted with OA, and factors contributing  to this crippling, chronic degenerative joint disease include aging, injury, obesity, genetics, immune status and nutritional deficiency.  Until recently, OA-associated pain has commonly been managed with the use of non-steroidal anti-inflammatory drugs (NSAIDs), but due to severe side effects in hepatic, renal, and cardiovascular systems, nutraceuticals have been preferred over NSAIDs. Presently, a number of nutraceuticals (glucosamine and chondroitin, type II collagen, Terminalia chebula extract, curcumin, green-lipped mussels, Boswellia serrata extract, shilajit, krill oil fatty acids, methylsulfonylmethane, hyaluronic acid, and others) are indicated singly or in a combination to manage/treat OA in companion animals.  However, nutraceutical efficacy depends on selection, source, dose and the right combination of ingredients.  In general, most nutraceuticals are effective and well tolerated with a wide margin of safety. However, they have not been evaluated for their pharmacological efficacy and safety in large clinical trials. Therapeutic efficacy and safety evaluation of plant-based nutraceuticals, compared to a pure synthetic compound, is complex due to a large number of factors.  In conclusion, the future of nutraceuticals in animal health and diseases seems bright, as novel nutraceuticals will emerge and new uses of old nutraceuticals will be discovered.

Speaker Presentations

Speaker PDFs